Innate Pharma has started a new program named IPH43, to develop an anti-MICA therapeutic antibody in oncology. The program is the newest to emerge from the company's discovery platform. MICA, which is highly polymorphic ligand of the NK ...
Tags: Innate Pharma, Anti-Mica Antibody
Scientists from the medical sciences division at Penn State University have discovered that a compound in fish oil appears to target leukemia stem cells and could lead to a cure for the disease. The compound is a natural extract from EPA, ...
Over the past several years, astaxanthin has earned a reputation as one of the most potent and powerful nutritional supplements ever made. I first began spreading the word about astaxanthin in 2004 when I toured the BioAstin production farm ...
Tags: Fish Oil, Agriculture, Food
Preliminary studies identified the presence of breast cancer cells from serum biomarkers indicating a blood test may be possible, U.S. researchers say. Study leader biomedical engineer Tony Hu of Houston Methodist Research Institute in ...
US-based CEL-SCI has obtained an approval from the Health Protection Administration, Ministry of Health, of the Croatian Republic to begin patient enrollment in Phase III clinical trial of its investigational cancer immunotherapy treatment, ...
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...
Tags: NanoString, DX Analysis System
US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
US-based Advanced Proteome Therapeutics has announced the achievement of an important milestone in its Cprogram with its collaborators by demonstrating that the first of a series of the company's site-specifically labeled protein conjugates ...
Tags: therapeutics, anti-cancer, proteome, Cprogram
IceCure Medical has announced that the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California, treated its first breast cancer patient using the IceSense3 cryoablation system in a pilot study evaluating ...
As cholesterol is metabolized, a potent stimulant of breast cancer is created -- one that fuels estrogen-receptor positive breast cancers, U.S. researchers say. Senior author Dr. Philip Shaul, professor and vice chair for research in ...
Tags: cholesterol, breast cancer, hormone, endocrine
Novocure announced that the US Food and Drug Administration (FDA) has approved the NovoTAL (Transducer Array Layout) system through a premarket approval (PMA) supplement. The NovoTAL System allows certified physicians to use the ...
Tags: Novotal System
Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...
Tags: Cancer Drug, Medicine
Advanced Medical Isotope (AMIC), a developer of medical isotopes, has filed 510(k) pre-market notification to the US Food and Drug Administration (FDA) approval for its Yttrium-90 RadioGel brachytherapy cancer product. In accordance to ...
Synta Pharmaceuticals has announced the publication of the company's first patent application covering its proprietary Hsp90-inhibitor drug conjugate (HDC) platform, which leverages the company's expertise in chaperone biology and medicinal ...
Calithera Biosciences has completed a $35m series D financing led by Adage Capital Partners, LP. Joining Adage as new investors in this financing are the Longwood Fund and two other institutional investor groups. The transaction also ...